These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 506600)

  • 61. [Zoological factors attending the existence of certain natural tularemia foci].
    Kucheruk VV; Kulik IL; Nikitina NA; Panteleev PA; Rubina MA; Tunikova NV
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Jun; 42(6):80-5. PubMed ID: 5895772
    [No Abstract]   [Full Text] [Related]  

  • 62. Francisella tularensis vaccines.
    Oyston PC
    Vaccine; 2009 Nov; 27 Suppl 4():D48-51. PubMed ID: 19837286
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunological markers that correlate with protection immunity against tularemia infection.
    Firstova VV; Mokrievich AN; Pavlov VM; Gorbatov AA; Kombarova TI; Biketov SF; Dyatlov IA
    Adv Exp Med Biol; 2014; 808():15-23. PubMed ID: 24595607
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tularemia revisited.
    Hornick R
    N Engl J Med; 2001 Nov; 345(22):1637-9. PubMed ID: 11757513
    [No Abstract]   [Full Text] [Related]  

  • 65. [Characteristics of natural foci of tularemia in the Khabarovsk region].
    Busoedova NM; Antip'Eva OA; Lipaev VM; Kozlovskaia OL; Chernykh PA
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Apr; 48(4):26-31. PubMed ID: 5561302
    [No Abstract]   [Full Text] [Related]  

  • 66. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
    Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
    Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
    McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS
    Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Environmental Monitoring and Surveillance of Rodents and Vectors for Francisella tularensis Following Outbreaks of Human Tularemia in Georgia.
    Elashvili E; Kracalik I; Burjanadze I; Datukishvili S; Chanturia G; Tsertsvadze N; Beridze L; Shavishvili M; Dzneladze A; Grdzelidze M; Imnadze P; Pearson A; Blackburn JK
    Vector Borne Zoonotic Dis; 2015 Oct; 15(10):633-6. PubMed ID: 26394283
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tularemia.
    Nigrovic LE; Wingerter SL
    Infect Dis Clin North Am; 2008 Sep; 22(3):489-504, ix. PubMed ID: 18755386
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Importance of surveillance of tularemia natural foci in the known endemic area of Central Europe, 1991-1997.
    Gurycová D; Výrosteková V; Khanakah G; Kocianová E; Stanek G
    Wien Klin Wochenschr; 2001 Jun; 113(11-12):433-8. PubMed ID: 11467089
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Tularemia vaccine strain is a potential vector].
    Pavlov VM; Mokrievich AN; Noskov AN; Urakov NN
    Vestn Ross Akad Med Nauk; 1997; (6):30-2. PubMed ID: 9289276
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Live vaccine strain Francisella tularensis is detectable at the inoculation site but not in blood after vaccination against tularemia.
    Hepburn MJ; Purcell BK; Lawler JV; Coyne SR; Petitt PL; Sellers KD; Norwood DA; Ulrich MP
    Clin Infect Dis; 2006 Sep; 43(6):711-6. PubMed ID: 16912944
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain.
    Elkins KL; Cowley SC; Bosio CM
    Microbes Infect; 2003 Feb; 5(2):135-42. PubMed ID: 12650771
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Francisella tularensis infection, or how to outsmart the certain death].
    Andelová H
    Acta Medica (Hradec Kralove) Suppl; 2004; 47(1):13-7. PubMed ID: 15745053
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Evaluation of immunobiological activity of Francisella tularensis C-complex preparations as promising component of subunit vaccines].
    Volokh OA; Shepelev IA; Firsova VV; Khramkova EM; Avdeeva NG; Samokhvalova IuI; Eremin SA; Diatlov IA; Zhemchugov VE
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (3):16-21. PubMed ID: 17672125
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.
    Shen H; Chen W; Conlan JW
    Microb Pathog; 2004 Aug; 37(2):107-10. PubMed ID: 15312850
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The determination of the duration of postvaccinal immunity against tularemia].
    Savel'eva RA; Ananova EV; Pronin AV; Fominykh EA; Rodionova IV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):51-2. PubMed ID: 8553755
    [No Abstract]   [Full Text] [Related]  

  • 78. Abiotic and Biotic Contributors to Support Inter-Epidemic Francisella tularensis in an Agricultural Peri-Urban Environment.
    Roth TM; Foley J; Wright S
    Vector Borne Zoonotic Dis; 2017 Nov; 17(11):764-772. PubMed ID: 28968195
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bacteriological study of a natural focus of tularemia in the Lake Reserve of Srebrna, the Silistra region, Bulgaria.
    Dinev T; Zlatanov Z
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(3):341-5. PubMed ID: 4673074
    [No Abstract]   [Full Text] [Related]  

  • 80. Vaccines against Francisella tularensis.
    Wayne Conlan J; Oyston PC
    Ann N Y Acad Sci; 2007 Jun; 1105():325-50. PubMed ID: 17395730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.